Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03664830 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease

Study acronym: PISMO
StatusActive, Not Recruiting
PhasePhase 1
Started2018-09-19
View on ClinicalTrials.gov ↗
The objective of this study is to investigate if up to two injections of plerixafor represent a safe and effective strategy to mobilize adequate numbers of CD34+ hematopoietic stem progenitor cells (HSPC) for autologous hematopoietic cell transplantation (HCT) in sickle cell disease (SCD) patients

Amendment history 2 changes detected by DataLookout

2026-09-03
Primary completion pushed: 2026-08-03 → 2027-07-06
2026-09-03
Completion pushed: 2026-08-03 → 2027-07-06
Trial Details
NCT Number NCT03664830
Lead Sponsor City of Hope Medical Center
Conditions Sickle Cell Disease
Enrollment 5 participants
Start Date 2018-09-19
Primary Completion 2027-07-06 (estimated)
Study Completion 2027-07-06 (estimated)
Updated on ClinicalTrials.gov 2026-09-02